Diffusion Pharmaceuticals Inc (NASDAQ:DFFN)

0.26
Delayed Data
As of Jan 26
 -0.0048 / -1.81%
Today’s Change
0.22
Today|||52-Week Range
1.85
-14.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$27.5M

Company Description

Diffusion Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of treatment for life threatening conditions. It offers Trans Sodium Crocetinate. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.

Contact Information

Diffusion Pharmaceuticals, Inc.
1317 Carlton Avenue
Charlottesville Virginia 22902-8759
P:(434) 220-0718
Investor Relations:

Employees

Shareholders

Mutual fund holders8.24%
Other institutional0.91%
Individual stakeholders0.16%

Top Executives

Robert J. CobuzziPresident, Chief Executive Officer & Director
William HornungChief Financial Officer
Christopher D. GallowayChief Medical Officer
Harry N. CookVice President-Clinical Operations
William R. ElderSecretary & General Counsel